Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
Authors
Keywords
-
Journal
IMMUNOLOGICAL INVESTIGATIONS
Volume 46, Issue 3, Pages 221-238
Publisher
Informa UK Limited
Online
2017-03-14
DOI
10.1080/08820139.2017.1280051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
- (2016) Holbrook E. Kohrt et al. Journal for ImmunoTherapy of Cancer
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes
- (2015) Daniele Mennonna et al. GUT
- Epigenetic treatment of solid tumours: a review of clinical trials
- (2015) Clara Nervi et al. Clinical Epigenetics
- Prime time for immune-checkpoint targeted therapy at ASCO 2015
- (2015) Aurélien Marabelle et al. OncoImmunology
- Tie2/TEK Modulates the Interaction of Glioma and Brain Tumor Stem Cells with Endothelial Cells and Promotes an Invasive Phenotype
- (2015) Oncotarget
- Antitumoral activity of allosteric inhibitors of Protein kinase CK2
- (2015) Virginie Moucadel et al. Oncotarget
- Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
- (2015) Xuekai Zhu et al. Oncotarget
- Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
- (2014) Rena Morita et al. CANCER SCIENCE
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA
- (2014) F. Riccardo et al. CLINICAL CANCER RESEARCH
- Mining CK2 in Cancer
- (2014) Charina E. Ortega et al. PLoS One
- Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
- (2014) M Signore et al. Cell Death & Disease
- Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma
- (2014) Zhe Bao Wu et al. Journal of Immunology Research
- Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
- (2014) Rachel E Beard et al. Journal for ImmunoTherapy of Cancer
- T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
- (2013) C. Geldres et al. CLINICAL CANCER RESEARCH
- Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4
- (2013) A. Volonte et al. JOURNAL OF IMMUNOLOGY
- Novel Neutralizing Hedgehog Antibody MEDI-5304 Exhibits Antitumor Activity by Inhibiting Paracrine Hedgehog Signaling
- (2013) N. R. Michaud et al. MOLECULAR CANCER THERAPEUTICS
- Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
- (2013) Biljana Ljujic et al. Scientific Reports
- Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy
- (2013) Jianfei Ji et al. Stem Cells Translational Medicine
- Stem-like Tumor-Initiating Cells Isolated from IL13R 2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
- (2012) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
- (2012) Christina Scheel et al. SEMINARS IN CANCER BIOLOGY
- Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells
- (2012) Kristel Kemper et al. STEM CELLS
- Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4
- (2011) X. Wang et al. CANCER RESEARCH
- Targeting ALDHbright Human Carcinoma-Initiating Cells with ALDH1A1-Specific CD8+ T Cells
- (2011) C. Visus et al. CLINICAL CANCER RESEARCH
- The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma
- (2011) Wei Hua et al. JOURNAL OF NEURO-ONCOLOGY
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
- (2011) Matthew A. Price et al. Pigment Cell & Melanoma Research
- Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
- (2010) Anna L. Stratford et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
- (2010) J. Wei et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Immunity and Cancer Stem Cells
- (2009) Tobias Schatton et al. Annals of the New York Academy of Sciences
- The Tortoise and the Hair: Slow-Cycling Cells in the Stem Cell Race
- (2009) Elaine Fuchs CELL
- DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
- (2009) Timothy Hoey et al. Cell Stem Cell
- Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
- (2009) Hervé Acloque et al. JOURNAL OF CLINICAL INVESTIGATION
- Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
- (2008) M. G. Francipane et al. CANCER RESEARCH
- MCF7 Side Population Cells with Characteristics of Cancer Stem/Progenitor Cells Express the Tumor Antigen MUC1
- (2008) K. Engelmann et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More